Search Results 2011-2020 of 19653 for Hemoglobin

  1. Clinical trials - Oncology (Medical)

    In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a ...

  2. Oncology (Medical) - Clinical trials

    In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a ...

  3. Clinical trials - Oncology (Medical)

    In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a ...

  4. Clinical trials - Oncology (Medical)

    In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a ...

  5. Lasofoxifene and Abemaciclib to the Combination of Fulvestrant and Abemaciclib for Locally Advanced or Metastatic ER+/HER2− Breast Cancer - Mayo Clinic

    Hemoglobin :2:8.0 g/dl (80 g/L);; ALT and AST levels::S3 upper limit of normal (ULN) or ::S5 in the presence of liver metastasis;; Total serum bilirubin ::Sl ...

  6. Study to Compare Adjuvant Immunotherapy of Bempegaldesleukin Combined With Nivolumab Versus Nivolumab After Complete Resection of Melanoma in Patients at High Risk for Recurrence - Mayo Clinic

    Hemoglobin ≥ 9.0 g/dL (90 g/L);; Platelet count ≥ 100 × 109 /L;; Total bilirubin ≤ 1.5 × upper limit of normal (ULN) (except patients with Gilbert Syndrome ...

  7. A Study to Test the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) with One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors - Mayo Clinic

    ... hemoglobin ≥9 g/dL (transfusion of PRBCs allowed) serum albumin ≥3.2g/dL lipase and amylase ≤2.0 × ULN and no radiologic (on baseline anatomical imaging) ...

  8. Study of E7386 in Participants With Selected Advanced Neoplasms - Mayo Clinic

    - Hemoglobin ≥ 9.0 grams per deciliter (g/dL). - Adequate liver function: - Total bilirubin ≤ 1.5 × ULN; - Alanine aminotransferase (ALT) and aspartate ...

  9. A Study to Evaluate PDS0101 and Pembrolizumab Combination to Treat Subjects with HPV16 + Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma - Mayo Clinic

    progression has been demonstrated in such lesions. - Have adequate organ function as defined in Hematological: ANC ≥1500/?L, Platelets ≥100 000/?L; Hemoglobin ...

  10. Neurology - Clinical trials

    In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a ...